BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Pardes Goes from Stealth to SPAC in Less than Two Years with COVID-19 Pill

  The COVID-19 pandemic has led to faster R&D, faster approvals, faster science than ever before. It’s even leading to faster company development.

  June 30, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Innate Pharma’s ANKET NK Engager Platform Eradicates Tumors Safely and Efficiently

  Innate Pharma has an alternative to T cell-based immunotherapy that has the potential to quickly and safely eradicate solid and metastatic tumors in the body.

  June 30, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  FUJIFILM Diosynth to Expand Manufacturing Capabilities With $850 Million Infusion

  The cash infusion will support the growth of its manufacturing capabilities in the US and the UK and the demands for gene therapies, antibodies, and vaccines such as COVID-19.

  June 30, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  Research Roundup: Big Focus on Alzheimer’s Disease and More

  Every week there are numerous scientific studies published. This week there was an unusual number of research stories revolving around Alzheimer’s disease. Here’s a look at some of the more interesting ones.

  June 30, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  FDA

  ICYMI: Promising Study Results, Funding and More

  Life sciences news sometimes flies under the radar. So here’s a look at a few stories you may have missed.

  June 30, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  How the U.S. Military Primed Windtree CEO Craig Fraser for C-Suite Success

  Craig Fraser, CEO of Windtree Therapeutics, became a U.S. Marine at age 17, learning to perform and lead under pressure in the field before eventually leading in the C-suite.

  June 30, 2021

   · 

  6 min read

   · 

  Gail Dutton
• 

  Business

  QIAGEN Partners with Verogen to Bolster Forensics Field

  The two companies will collaborate to market Verogen’s forensically validated NGS workflows alongside QIAGEN’s full range of forensic-grade chemistries and sample prep automation.

  June 30, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Poor Results Force Biotech Firm To Halt Trials for Intranasal COVID-19 Vaccine

  The company said it would halt activities and focus its resources and time on liver and obesity research following “disappointing” results of its intranasal COVID-19 vaccine.

  June 30, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Female-Founded Antheia Raises $73 Million to Support Synthetic Biology for Essential Medicines

  Christina Smolke said the financing will enable the company to use its synthetic biology platform to support essential medications that rely on plant-based materials.

  June 30, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  ArriVent Biopharma Launches with $150 Million Series A Financing

  The new funding will be used to advance the company’s potential best-in-class epidermal growth factor receptor tyrosine kinase inhibitor furmonertinib, a lung cancer treatment that has been licensed from Allist Pharmaceuticals.

  June 30, 2021

   · 

  2 min read

   · 

  Brandon May